The Vimentin (Phospho-Ser56) Colorimetric Cell-Based ELISA Kit is a convenient, lysate-free, high throughput and sensitive assay kit that can detect Vimentin protein phosphorylation and expression profile in cells. The kit can be used for measuring the relative amounts of phosphorylated Vimentin in cultured cells as well as screening for the effects that various treatments, inhibitors (ie. siRNA or chemicals), or activators have on Vimentin phosphorylation.
Details
-
Product Name
Vimentin (Phospho-Ser56) Colorimetric Cell-Based ELISA Kit
-
Catalog No
CBP1485
-
Detection Method
Colorimetric 450 nm
-
Dynamic Range
> 5000 Cells
-
Storage/Stability
4°C/6 Months
-
Reactivity
Human
-
Assay Type
Cell-Based
-
Database Links
Gene ID: 7431, UniProt ID: P08670, OMIM #: 193060, Unigene #: Hs.642813
-
Format
2 x 96-Well Microplates
-
Manual (PDF)
-
NCBI Gene Symbol
VIM
-
Sub Type
Phospho
-
Synonyms
VIME, vimentin
-
TargetName
Vimentin (Phospho-Ser56)
Application Images
Western blot analysis of extracts from A549 cells treated with Nocodazole 1ug/ml 16h, using Vimentin (Phospho-Ser56) Antibody.
An illustrated breakdown of the colorimetric Non-Phospho Cell-Based ELISA assay principles.
A short protocol of the steps taken in Assay Biotechnology's Cell-Based ELISA Kits.
The Anti-GAPDH Antibody is a mouse monoclonal antibody used as a positive control in Assay Biotechnology's Cell-Based ELISA kits. It was tested on Western Blots with the tissue lysates from human, mouse, and rat for specificity.
|
Western blot analysis of extracts from A549 cells treated with Nocodazole 1ug/ml 16h, using Vimentin (Phospho-Ser56) Antibody. |
|
An illustrated breakdown of the colorimetric Non-Phospho Cell-Based ELISA assay principles. |
|
A short protocol of the steps taken in Assay Biotechnology's Cell-Based ELISA Kits. |
|
The Anti-GAPDH Antibody is a mouse monoclonal antibody used as a positive control in Assay Biotechnology's Cell-Based ELISA kits. It was tested on Western Blots with the tissue lysates from human, mouse, and rat for specificity. |
Follow us on Twitter
Follow us on Linkedin
Like us on Facebook
Subscribe to our Channel